Bolt Biotherapeutics, Inc. Other Non-Current Assets
Bolt Biotherapeutics, Inc. (BOLT) had Other Non-Current Assets of $87.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Noncurrent $87.00K.
- 2026-03-31: Other Assets, Noncurrent $112.00K.
- 2025-12-31: Other Assets, Noncurrent $138.00K.
- 2025-09-30: Other Assets, Noncurrent $179.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $87.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $112.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $138.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $179.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $222.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $51.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $62.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $287.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $308.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.76M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.82M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.34M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.01M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.03M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.03M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $1.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $997.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $916.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.04M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $990.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $867.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $208.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $909.00K 10-K · filed 2022-03-30 | $875.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |